Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 9 | 2024 | 496 | 1.940 |
Why?
|
| Immunity, Innate | 5 | 2024 | 766 | 1.050 |
Why?
|
| Cyclic GMP | 3 | 2022 | 28 | 1.040 |
Why?
|
| Drug Delivery Systems | 4 | 2024 | 307 | 0.840 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2024 | 348 | 0.790 |
Why?
|
| Antigen-Presenting Cells | 3 | 2021 | 176 | 0.720 |
Why?
|
| Gold | 4 | 2017 | 227 | 0.710 |
Why?
|
| Metal Nanoparticles | 4 | 2017 | 180 | 0.690 |
Why?
|
| Neoplasms | 4 | 2024 | 1242 | 0.660 |
Why?
|
| Melanoma, Experimental | 1 | 2019 | 42 | 0.650 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2019 | 62 | 0.650 |
Why?
|
| Nanocapsules | 1 | 2019 | 21 | 0.650 |
Why?
|
| Lipid A | 1 | 2019 | 70 | 0.650 |
Why?
|
| Interferon-beta | 1 | 2019 | 76 | 0.640 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2019 | 59 | 0.620 |
Why?
|
| Lipid Bilayers | 2 | 2018 | 49 | 0.620 |
Why?
|
| Permeability | 1 | 2018 | 48 | 0.600 |
Why?
|
| Membrane Fusion | 1 | 2018 | 74 | 0.580 |
Why?
|
| Blood Vessels | 1 | 2016 | 61 | 0.520 |
Why?
|
| Molecular Imaging | 1 | 2016 | 47 | 0.520 |
Why?
|
| Glycocalyx | 1 | 2015 | 3 | 0.510 |
Why?
|
| Erythrocyte Membrane | 1 | 2015 | 24 | 0.500 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 174 | 0.490 |
Why?
|
| Immunotherapy | 5 | 2024 | 231 | 0.490 |
Why?
|
| Immunologic Factors | 2 | 2022 | 99 | 0.350 |
Why?
|
| Tumor Microenvironment | 4 | 2024 | 143 | 0.350 |
Why?
|
| Pancreatic Neoplasms | 2 | 2024 | 317 | 0.330 |
Why?
|
| Animals | 11 | 2024 | 19647 | 0.300 |
Why?
|
| Mice | 9 | 2024 | 10266 | 0.260 |
Why?
|
| Drug Carriers | 3 | 2024 | 171 | 0.250 |
Why?
|
| Immunization | 2 | 2022 | 127 | 0.230 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2024 | 104 | 0.220 |
Why?
|
| Dermatitis | 1 | 2023 | 29 | 0.210 |
Why?
|
| Methotrexate | 1 | 2023 | 76 | 0.210 |
Why?
|
| Nanostructures | 1 | 2024 | 174 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 5 | 2024 | 3194 | 0.200 |
Why?
|
| Neoadjuvant Therapy | 1 | 2022 | 70 | 0.190 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2022 | 646 | 0.190 |
Why?
|
| Mice, Inbred BALB C | 2 | 2022 | 880 | 0.190 |
Why?
|
| Theranostic Nanomedicine | 1 | 2020 | 6 | 0.180 |
Why?
|
| Ligands | 2 | 2022 | 422 | 0.180 |
Why?
|
| Cytokines | 1 | 2024 | 906 | 0.180 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 35 | 0.170 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2019 | 83 | 0.170 |
Why?
|
| Microcirculation | 1 | 2019 | 50 | 0.160 |
Why?
|
| Drug Synergism | 1 | 2019 | 133 | 0.160 |
Why?
|
| Static Electricity | 2 | 2018 | 165 | 0.160 |
Why?
|
| Glioblastoma | 1 | 2021 | 156 | 0.160 |
Why?
|
| Particle Size | 2 | 2018 | 399 | 0.160 |
Why?
|
| Boron Compounds | 1 | 2018 | 18 | 0.150 |
Why?
|
| Killer Cells, Natural | 1 | 2019 | 214 | 0.150 |
Why?
|
| Liposomes | 1 | 2018 | 98 | 0.150 |
Why?
|
| Brain Neoplasms | 1 | 2021 | 306 | 0.140 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 376 | 0.140 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 249 | 0.140 |
Why?
|
| Single-Cell Analysis | 1 | 2017 | 85 | 0.130 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 286 | 0.120 |
Why?
|
| Atherosclerosis | 1 | 2016 | 147 | 0.120 |
Why?
|
| Dendritic Cells | 4 | 2022 | 509 | 0.120 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 1129 | 0.110 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2011 | 27 | 0.100 |
Why?
|
| Humans | 5 | 2024 | 59491 | 0.090 |
Why?
|
| Interferon Type I | 2 | 2024 | 169 | 0.090 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 1373 | 0.080 |
Why?
|
| Ovalbumin | 1 | 2009 | 114 | 0.080 |
Why?
|
| Gels | 1 | 2009 | 59 | 0.080 |
Why?
|
| T-Lymphocytes | 2 | 2024 | 965 | 0.080 |
Why?
|
| Cytosol | 1 | 2009 | 169 | 0.080 |
Why?
|
| Influenza A virus | 1 | 2009 | 117 | 0.070 |
Why?
|
| DNA | 1 | 2011 | 794 | 0.070 |
Why?
|
| Macrophages | 2 | 2022 | 1007 | 0.060 |
Why?
|
| Female | 4 | 2021 | 30906 | 0.060 |
Why?
|
| Cellular Senescence | 1 | 2024 | 104 | 0.060 |
Why?
|
| Nod1 Signaling Adaptor Protein | 1 | 2023 | 12 | 0.050 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2023 | 26 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 851 | 0.050 |
Why?
|
| Peptidoglycan | 1 | 2023 | 54 | 0.050 |
Why?
|
| 1,2-Dipalmitoylphosphatidylcholine | 1 | 2022 | 4 | 0.050 |
Why?
|
| Phosphatidylethanolamines | 1 | 2022 | 17 | 0.050 |
Why?
|
| Phosphatidylcholines | 1 | 2022 | 35 | 0.050 |
Why?
|
| Mammals | 1 | 2023 | 204 | 0.050 |
Why?
|
| Porosity | 1 | 2021 | 38 | 0.050 |
Why?
|
| RAW 264.7 Cells | 1 | 2021 | 47 | 0.050 |
Why?
|
| Ferric Compounds | 1 | 2020 | 38 | 0.050 |
Why?
|
| Nanomedicine | 1 | 2020 | 24 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2023 | 375 | 0.040 |
Why?
|
| Silicon Dioxide | 1 | 2021 | 59 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2022 | 162 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2024 | 842 | 0.040 |
Why?
|
| Peptides | 1 | 2022 | 549 | 0.040 |
Why?
|
| Inflammation | 1 | 2023 | 1102 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2017 | 283 | 0.030 |
Why?
|
| Vaccines | 1 | 2017 | 97 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 645 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2024 | 2890 | 0.030 |
Why?
|
| Melanoma | 1 | 2017 | 334 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2013 | 492 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 193 | 0.020 |
Why?
|
| Surface Properties | 1 | 2009 | 271 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2009 | 174 | 0.020 |
Why?
|
| Endosomes | 1 | 2009 | 170 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2009 | 427 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2009 | 279 | 0.020 |
Why?
|
| Monocytes | 1 | 2009 | 351 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 1221 | 0.020 |
Why?
|